Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2018-05-23 History
Report ID 30895
Drug Identification Number 02330547
Brand name PIPERACILLIN SODIUM/TAZOBACTAM SODIUM POWDER FOR INJECTION
Common or Proper name PIPERACILLIN-TAZOBACTAM
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 12G 1.5G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 1 VIAL
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Shortage of an active ingredient.
Anticipated start date 2017-11-30
Actual start date 2017-12-15
Estimated end date 2018-05-11
Actual end date 2018-05-04
Shortage status Resolved
Updated date 2018-05-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2018-05-23 French Compare
v13 2018-05-23 English Compare
v12 2018-03-23 French Compare
v11 2018-03-23 English Compare
v10 2018-02-12 French Compare
v9 2018-02-12 English Compare
v8 2018-01-08 French Compare
v7 2018-01-08 English Compare
v6 2017-12-16 English Compare
v5 2017-12-15 French Compare
v4 2017-12-15 English Compare
v3 2017-12-01 English Compare
v2 2017-11-28 French Compare
v1 2017-11-28 English Compare

Showing 1 to 14 of 14